Newsletters
The Capitalist Newsletter – January 12, 2017
TRUMP MEETS WITH PRESS FOR FIRST TIME SINCE ELECTION; HERE’S WHAT WE LEARNED |
|
Winners & Losers – MYOS RENS Technology, Inc. (MYOS) Skyrockets UP (424.62%) After Amending and Restating Bylaws Following Supreme Court Win – EnteroMedics, Inc. (ETRM) Falls DOWN (44.77%) After Analysts Downgrade the Company Once Momentum Runs out on 1300% Climb Most Talked About MYOS RENS Technology, Inc. (MYOS) a Majority Strong Buy Following its Supreme Court Victory Preventing Insider Trading The TIP Sheets – Wednesday, January 11th – MYOS RENS Technology, Inc. (MYOS) Skyrockets UP (424.62%) After Amending and Restating Bylaws Following Supreme Court Win. The Verdict Prevents Insider Selling of 1.5m Shares of Common Stock. When Combined with the Far Too Fast Rise of the Stock on Wednesday, Expect Shares to Fall Back DOWN Unusual Volume – Biocept, Inc. (BIOC) Soars UP (49.72%) on 63m Shares Traded After Picking up Insurance Coverage from BCBS for Its Lead Biopsy Product. Biocept’s Commercial Application of This Technology Means Look for Shares to Continue UP |